Michael H. Mulroy - 22 Nov 2024 Form 4 Insider Report for Lineage Cell Therapeutics, Inc. (LCTX)

Role
Director
Signature
/s/ Daniel Collins, as Attorney-in-Fact
Issuer symbol
LCTX
Transactions as of
22 Nov 2024
Net transactions value
+$22,640
Form type
4
Filing time
25 Nov 2024, 16:30:03 UTC
Previous filing
03 Jul 2024
Next filing
02 Jul 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LCTX Common Shares Purchase $22,640 +40,000 +15% $0.5660 298,555 22 Nov 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.